C-Reactive Protein Testing Market to Reach $3.56 Bn, Globally, by 2030 at 2.4% CAGR: Allied Market Research

Increase in demand for healthcare services from aging population, surge in prevalence for chronic diseases, and high-end technological advancements in the field of c-reactive protein testing drive the growth of the global c-reactive protein testing market.

PORTLAND, Ore., Feb. 23, 2022 /PRNewswire/ -- Allied Market Research published a report, titled, "C-Reactive Protein Testing Market by Assay Type (Enzyme-Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CLIA), Immunoturbidimetric Assay, and Others) and Application (Diabetes, Rheumatoid Arthritis, Cardiovascular Disease, Inflammatory Bowel Disease, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030." According to the report, the global c-reactive protein testing industry was estimated at $2.76 billion in 2020, and is anticipated to hit $3.56 billion by 2030, registering a CAGR of 2.4% from 2021 to 2030.

For Right Perspective and Competitive Insights, Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/304

Drivers, restraints, and opportunities-

Increase in demand for healthcare services from aging population, surge in prevalence for chronic diseases, and high-end technological advancements in the field of c-reactive protein testing drive the growth of the global c-reactive protein testing market. On the other hand, availability of alternative disease testing methods restrain the growth to some extent. However, surge in adoption of point-of-care tests is expected to create lucrative opportunities in the industry.

Covid-19 Scenario-

• C-reactive protein (CRP) has been identified as an important marker that increases significantly in severe COVID-19 patients. Therefore, CRP testing has experienced a steep incline in the last two years, thus driving the market significantly.
• This trend is most likely to continue till the pandemic is completely over.

The immunoturbidimetric assay segment to maintain its lion's share-

On the basis of assay type, the immunoturbidimetric assay segment accounted for the highest market share in 2020, generating nearly half of the global c-reactive protein testing market. Emergence of large number of rapid kits based on immunoturbidimetric assays drives the segment growth. The Chemiluminescence Immunoassay (CLIA) segment, however, is anticipated to cite the fastest CAGR of 3.6% from 2021 to 2030, due to its higher sensitivity, good specificity, and wide range of applications.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert: https://www.alliedmarketresearch.com/purchase-enquiry/304

The cardiovascular disease segment to lead the trail-

On the basis of application, the cardiovascular disease segment generated the highest share in 2020, holding nearly two-thirds of the global c-reactive protein testing market, owing to rise in number of cardiovascular diseases. The diabetes segment, on the other hand, is expected to cite the fastest CAGR of 3.9% from 2021 to 2030. This is attributed to the significant rise in the number of population suffering from diabetes.

North America to dominate by 2030-

On the basis of region, North America contributed to the major market share in terms of revenue 2020, holding more than two-fifths of the global c-reactive protein testing market, due to rise in chronic diseases, rapid adoption of advanced technologies like point of care devices, and the presence of key players across North America. Asia-Pacific, simultaneously, is projected to cite the fastest CAGR of 4.00% from 2021 to 2030. This is due to rapidly growing geriatric population, the continuous government support for pharmaceutical and biotechnology related R&D activities, surge in public–private investments, and rise in the number of initiatives for early diagnosis in the region.

Prominent market players-

• Danaher Corporation (Beckman Coulter Inc.)
• F. Hoffmann-La Roche AG
• Horiba, Ltd.
• Laboratory Corporation of America Holdings
• Zoetis Inc. (Abaxis Inc.).
• Quest Diagnostics Incorporated
• Merck KGAA (Millipore Sigma)
• Abbott Laboratories
• Randox Laboratories Limited
• Thermo Fisher Scientific, Inc.

Avenue Basic Plan | Library Access | 1 Year Subscription |

Sign up for Avenue subscription to access more than 12,000+ company profiles and 2,000+ niche industry market research reports at $699 per month, per seat. For a year, the client needs to purchase minimum 2 seat plan.

Request for 14 days free trial: https://www.alliedmarketresearch.com/avenue/trial/starter

"We have also published few syndicated market studies in the similar area that might be of your interest. Below are the report title for your reference, considering Impact of Covid-19 Over This Market which will help you to assess aftereffects of pandemic on short-term and long-term growth trends of this market."

Trending Reports in Healthcare Industry (Book Now with 10% Discount):

Telemedicine Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Digital PCR Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Orthobiologics Market - Global Opportunity Analysis and Industry Forecast, 2020-2030

Surgical Imaging Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

3D Printing Healthcare Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Track and Trace Solutions Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Lateral Flow Assays Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Veterinary Medicine Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Cell Culture Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

Antibiotics Market - Global Opportunity Analysis and Industry Forecast, 2020–2030

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com/reports-store/life-sciences
Follow Us on LinkedIn: https://www.linkedin.com/showcase/life-sciences-industry-research/

Logo: https://mma.prnewswire.com/media/636519/Allied_Market_Research_Logo.jpg